Asthma
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study and admixture mapping identify different asthma-associated loci in Latinos: the Genes-environments & Admixture in Latino Americans study.
|
24406073 |
2014 |
Ataxia
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Our study demonstrates that compound heterozygous mutations in VPS13D cause movement disorders along the ataxia-spasticity spectrum, making VPS13D the fourth VPS13 paralog involved in neurological disorders.Ann Neurol 2018.
|
29604224 |
2018 |
Ataxia
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ataxia, Spinocerebellar
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This included a large family with 5 affected siblings with spinocerebellar ataxia with saccadic intrusions (SCASI), or spinocerebellar ataxia, recessive, type 4 (SCAR4).
|
29604224 |
2018 |
Babinski Reflex
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebellar Ataxia
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Our study demonstrates that compound heterozygous mutations in VPS13D cause movement disorders along the ataxia-spasticity spectrum, making VPS13D the fourth VPS13 paralog involved in neurological disorders.Ann Neurol 2018.
|
29604224 |
2018 |
Distal amyotrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Distal muscle weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dystonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Frequent falls
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Gait Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypermetric saccades
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperreflexia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Left Bundle-Branch Block
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Compared to controls with scar, LBBB with scar had a lower LVEF (median [interquartile range] 27 [19-38] vs 36 [25-50] %, p < 0.001), smaller scar (4 [1-9] vs 11 [6-20] %LVM, p < 0.001), and greater dysfunction index (39 [30-52] vs 21 [12-35] % points, p < 0.001).
|
30497733 |
2019 |
Macrosaccadic oscillations
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Movement Disorders
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Our study demonstrates that compound heterozygous mutations in VPS13D cause movement disorders along the ataxia-spasticity spectrum, making VPS13D the fourth VPS13 paralog involved in neurological disorders.Ann Neurol 2018.
|
29604224 |
2018 |
Movement Disorders
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Recessive mutations in VPS13D cause childhood onset movement disorders.
|
29518281 |
2018 |
Muscle Spasticity
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects.
|
29604224 |
2018 |
Muscle Spasticity
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Muscular fasciculation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Muscular hypotonia of the trunk
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Myoclonus
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
nervous system disorder
|
0.020 |
GeneticVariation
|
group |
BEFREE |
We describe the first disease association of rare recessive VPS13D variants including frameshift, missense, and partial duplication mutations with a novel complex, hyperkinetic neurological disorder.
|
29518281 |
2018 |
nervous system disorder
|
0.020 |
Biomarker
|
group |
BEFREE |
Our study demonstrates that compound heterozygous mutations in VPS13D cause movement disorders along the ataxia-spasticity spectrum, making VPS13D the fourth VPS13 paralog involved in neurological disorders.Ann Neurol 2018.
|
29604224 |
2018 |